Telix Pharmaceuticals Limited

DB:T3X Stock Report

Market Cap: €5.0b

Telix Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:T3X Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Mar 25Buy€186,932Tiffany OlsonIndividual11,315€16.52
05 Mar 25Buy€58,568Marie McDonaldIndividual3,719€15.75
27 Feb 25Sell€548,516Harry McCannIndividual30,000€18.28
27 Feb 25Sell€35,450,169Christian BehrenbruchIndividual2,000,000€17.73
28 Aug 24Sell€23,138State Street Global Advisors, Inc.Company2,020€11.45
26 Aug 24Buy€816,322State Street Global Advisors, Inc.Company67,952€12.07
16 Aug 24Buy€5,532,594State Street Global Advisors, Inc.Company472,947€11.70
08 Aug 24Buy€11,318State Street Global Advisors, Inc.Company1,075€10.53
31 Jul 24Buy€4,326,010JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany373,846€11.95
31 Jul 24Buy€12,276,853JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,064,677€11.95
31 Jul 24Sell€2,173,233JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany187,541€11.95
31 Jul 24Sell€11,818,802JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,018,087€11.95
24 Jul 24Buy€59,051,099JP Morgan Asset ManagementCompany5,611,191€12.46
24 Jul 24Buy€34,148,430JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,004,521€12.35
24 Jul 24Sell€50,690,125JP Morgan Asset ManagementCompany4,861,777€12.45
24 Jul 24Sell€33,349,802JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,927,743€11.67
19 Jul 24Buy€24,950,555State Street Global Advisors, Inc.Company2,064,658€12.09
28 Jun 24Buy€25,339,512Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany2,384,435€11.45
28 Jun 24Sell€36,899,279Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany3,512,561€11.40
27 Jun 24Buy€324,763Eaton Vance ManagementCompany28,289€11.48
25 Jun 24Buy€82Morgan Stanley Investment Management Inc.Company7€11.70
21 Jun 24Buy€2,557,286Mitsubishi UFJ Asset Management Co., Ltd.Company240,115€11.45

Insider Trading Volume

Insider Buying: T3X insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of T3X?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,762,5000.521%
Public Companies10,947,1813.24%
Individual Insiders50,261,95014.9%
Institutions94,646,12528%
General Public180,351,90953.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 43.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.71%
Andreas Kluge
22,675,000€338.7m0%no data
6.4%
Christian Behrenbruch
21,628,298€323.0m-6.89%no data
6.28%
State Street Global Advisors, Inc.
21,229,560€317.1m21.2%0.01%
4.8%
The Vanguard Group, Inc.
16,227,659€242.4m1.86%no data
3.24%
Grand Pharmaceutical Group Limited
10,947,181€163.5m0%no data
1.97%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
6,667,490€99.6m0%0.02%
1.81%
Norges Bank Investment Management
6,123,515€91.5m0%0.01%
1.61%
UV-Cap GmbH & Co KG
5,427,233€81.1m-27.9%no data
1.35%
JP Morgan Asset Management
4,568,801€68.2m0%0.01%
1.35%
BlackRock, Inc.
4,553,840€68.0m4.12%no data
1.07%
Mark Nelson
3,628,750€54.2m0%no data
0.74%
Oncidium Foundation, Endowment Arm
2,513,616€37.5m-59.7%no data
0.66%
Veritas Asset Management LLP
2,227,032€33.3m0%0.21%
0.63%
JPMorgan Chase & Co, Brokerage and Securities Investments
2,130,144€31.8m0%0.01%
0.61%
RBC Global Asset Management Inc.
2,060,510€30.8m244%0.02%
0.59%
Netwealth Investments Ltd.
2,010,924€30.0m2.84%0.34%
0.52%
Yelwac Pty Ltd
1,762,500€26.3m-26%no data
0.49%
Van Eck Associates Corporation
1,647,819€24.6m-8.15%0.03%
0.47%
Hearts and Minds Investments Limited
1,585,001€23.7m0%5.85%
0.45%
BetaShares Capital Limited
1,532,030€22.9m11%0.13%
0.37%
AllianceBernstein L.P.
1,239,593€18.5m-0.06%0.01%
0.35%
Dimensional Fund Advisors LP
1,191,236€17.8m-12.2%no data
0.33%
Harry McCann
1,120,000€16.7m-2.61%no data
0.32%
Morgan Stanley, Investment Banking and Brokerage Investments
1,076,299€16.1m0%no data
0.32%
Mitsubishi UFJ Asset Management Co., Ltd.
1,076,118€16.1m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 01:02
End of Day Share Price 2025/05/16 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Telix Pharmaceuticals Limited is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
John HesterBell Potter
Andrew PaineCLSA